(Q34201717)

31 July 2017

1 reference

title

Embryo implantation and GnRH antagonists: ovarian actions of GnRH antagonists (English)

1 reference

31 July 2017

Ortmann O

1

1 reference

31 July 2017

Weiss JM

series ordinal

2

1 reference

31 July 2017

Diedrich K

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

16

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

608-611

1 reference

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.4.608

Specific binding of gonadotrophin-releasing hormone and an agonist to human corpus luteum homogenates: characterization, properties, and luteal phase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.4.608

Absence of gonadotropin-releasing hormone receptors in human gonadal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.4.608

Gonadotropin-releasing hormone analogue binds to luteal cells and inhibits progesterone production

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.4.608

High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.4.608

Effect of the gonadotropin-releasing hormone antagonist ganirelix on cyclic adenosine monophosphate accumulation of human granulosa-lutein cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.4.608

Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.4.608

Effects of gonadotrophin-releasing hormone agonists on human ovarian steroid secretion in vivo and in vitro-results of a prospective, randomized in-vitro fertilization study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.4.608

Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.4.608

GnRH receptor mRNA expression by in-situ hybridization in the primate pituitary and ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.4.608

Extrapituitary Actions of Gonadotropin-Releasing Hormone*

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.4.608

Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.4.608

Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.4.608

Effect of gonadotrophin-releasing hormone and related analogue on human luteal cell function in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.4.608

Can GnRH agonists act directly on the ovary and contribute to cyst formation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.4.608

Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.4.608

Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.4.608

Expression and regulation of gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acids in human granulosa-luteal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.4.608

Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.4.608

Dose relationship between GnRH antagonists and pituitary suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.4.608

Direct effects of gonadotropin-releasing hormone on the ovary in rats and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.4.608

21 January 2018

Identifiers

DOI

10.1093/HUMREP/16.4.608

1 reference

31 July 2017

1 reference